Status:

RECRUITING

Prevention of Suicidal Behavior Through the VIGILANS Protocol: the Restoration of Social Connection Hypothesis

Lead Sponsor:

University Hospital, Montpellier

Conditions:

Suicidal Behaviour Disorder

Eligibility:

All Genders

18-55 years

Phase:

NA

Brief Summary

The World Health Organization (WHO) estimates, with 800,000 annual deaths, that suicide is the second leading cause of death in people aged 10 to 44 and thus recognizes suicide prevention as a public ...

Detailed Description

Main Objective : To compare the cortisol response to an experimental social stress task, the virtual trier social stress test (V-TSST), between patients who performed a relapse in suicide attempt (TS...

Eligibility Criteria

Inclusion

  • For all subjects:
  • Patients benefiting from VigilanS monitoring at CHU Montpellier / Nîmes
  • aged between 18 and 55 years old;
  • able to understand experimental procedures
  • able to speak, read and understand French
  • able to give written informed consent
  • Specific inclusion criteria:
  • TS+: Had an actual suicide according to C-SSRS suicidal recurrence during the 6 months prior to VigilanS
  • TS-: Had not suffered a suicidal recurrence during the 6 months prior to VigilanS

Exclusion

    Key Trial Info

    Start Date :

    September 12 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 13 2027

    Estimated Enrollment :

    120 Patients enrolled

    Trial Details

    Trial ID

    NCT05227183

    Start Date

    September 12 2024

    End Date

    September 13 2027

    Last Update

    October 2 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Maude SENEQUE

    Montpellier, France, 34000